Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Orphan Europe SARL, Immeuble Le Wilson, 70, Avenue du General de Gaulle, F-92 800 Puteaux, France
Cystadane 1 g oral powder.
| Pharmaceutical Form |
|---|
|
Oral powder. White crystalline free flowing powder. |
1 g of powder contains 1 g of betaine anhydrous.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Betaine |
Betaine is a methyl derivative of glycine first isolated from the juice of sugar beets. Betaine participates in the methionine cycle, which produces vital biomolecules including proteins, hormones, phospholipids, polyamines, and nutrients. Betaine is used as a dietary supplement and has a beneficial effect on the human health. The drug acts as a methyl group donor in the remethylation of homocysteine to methionine. |
| List of Excipients |
|---|
|
None. |
HDPE bottles with a child resistant closure.
Each pack contains 1 bottle with 180 g of powder and three measuring spoons.
Orphan Europe SARL, Immeuble “Le Wilson”, 70, Avenue du General de Gaulle, F-92 800 Puteaux, France
EU/1/06/379/001
Date of first authorisation: 15 February 2007
Date of latest renewal: 21 November 2016
| Drug | Countries | |
|---|---|---|
| CYSTADANE | Austria, Australia, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
